Cover |
Sep. 02, 2026 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | Vivos Therapeutics, Inc. (the “Company”) is filing this Amendment (the “Amendment”) to its Current Report on Form 8-K dated September 4, 2026 and filed with the Securities and Exchange Commission on September 8, 2026 the (the “Original 8-K”) to correct the date of the Original 8-K. The Original Form 8-K used August 31, 2026 as the Date of Report. The transactions disclosed under Items 1.01 and 3.02 were consummated on September 2, 2026. This Amendment is being filed solely to reflect September 2, 2026 as the Date of Report and to amend Items 1.01 and 3.02 thereof to reflect the fact that the transactions reported in the Original 8-K were consummated on September 2, 2026. |
| Document Period End Date | Sep. 02, 2026 |
| Entity File Number | 001-39796 |
| Entity Registrant Name | Vivos Therapeutics, Inc. |
| Entity Central Index Key | 0001716166 |
| Entity Tax Identification Number | 81-3224056 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 7921 Southpark Plaza |
| Entity Address, Address Line Two | Suite 210 |
| Entity Address, City or Town | Littleton |
| Entity Address, State or Province | CO |
| Entity Address, Postal Zip Code | 80120 |
| City Area Code | (866) |
| Local Phone Number | 908-4867 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.0001 per share |
| Trading Symbol | VVOS |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |